Nilai Buku saben Saham: BeyondSpring (BYSI)

The dynamics of capital per share demonstrate the evolution of BeyondSpring Inc. (BYSI) assets in its drive to expand markets for neutropenia drugs. The value of -0.86 determines the latest valuation metric. Stability is ensured by the strong pricing power of plinabulin, while structural flexibility is maintained through the full outsourcing of manufacturing and clinical trials.

BYSI - Nilai Buku Siji Saham BeyondSpring, Inc. ing rentang 04.07.2022 - 26.10.2026

Ringkesan rincian data analitis beyondspringpharma.com (BYSI)

- rega lan prakiraan konsensus rega:

Bagan rega BeyondSpring Pharma|BYSI - Target median analis

- data kapitalisasi pasar:

Kapitalisasi pasar BeyondSpring Inc.|BYSI - Rega Tumbas Perusahaan

- data kapitalisasi buku:

Nilai Buku saben Saham BeyondSpring|BYSI - Nilai Buku Bisnis|Rasio Kapitalisasi Pasar marang Nilai Buku beyondspringpharma.com|BYSI - Aset Perusahaan

- data utang lan likuiditas:

Utang marang Ekuitas BeyondSpring Inc.|BYSI - Rasio utang jangka dawa marang modal|Utang jangka cendhak marang modal BeyondSpring|BYSI - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku BeyondSpring Inc.

Pambiji fundamental perusahaan:BYSI BeyondSpring Pharma

Produk asil prodhuksi beyondspringpharma.com

Book value per share reflects the portion of equity attributable to a single security, allowing for an assessment of the business's intrinsic value net of all liabilities. By analyzing the historical book value per share chart, investors determine the asset's margin of safety, which is critical for BeyondSpring Inc. (BYSI) due to stringent government price regulations on pharmaceuticals in China.

Pesaing BeyondSpring Inc. (BYSI)